← Back to Analyst Consensus 
OMDA Buy
Omada Health, Inc.
Current Price —
Implied Upside —
Analysts 18
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Next Earnings
Nov 5, 2026 (10 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 14, 2026 | Freedom Capital Markets | maintain | Buy → Buy | — | 43% |
| Sep 14, 2026 | Freedom Capital Markets | maintain | Buy → Buy | — | 43% |
| Sep 11, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Sep 11, 2026 | Needham | reiterate | Buy → Buy | — | 50% |
| Sep 11, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Aug 14, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 54% |
| Aug 14, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 47% |
| Aug 12, 2026 | Baird | maintain | Neutral → Neutral | — | 55% |
| Aug 10, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Aug 3, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Jul 21, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Jul 20, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 47% |
| Jul 17, 2026 | BTIG | initiate | — → Buy | — | 52% |
| Jun 22, 2026 | Morgan Stanley | reiterate | Overweight → Overweight | — | 54% |
| May 8, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| May 8, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 47% |
| May 8, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| May 8, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| May 8, 2026 | Needham | reiterate | Buy → Buy | — | 50% |
| Apr 14, 2026 | Citizens | initiate | — → Market Outperform | — | 47% |
| Apr 9, 2026 | Goldman Sachs | maintain | Buy → Buy | — | 54% |
| Apr 8, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Mar 12, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 54% |
| Mar 6, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Mar 6, 2026 | BMO Capital | maintain | Outperform → Outperform | — | 53% |
| Mar 6, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Mar 6, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Mar 3, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Jan 22, 2026 | Needham | reiterate | Buy → Buy | $28 | 50% |
| Jan 9, 2026 | Wells Fargo | initiate | — → Equal-Weight | $17 | 54% |
| Jan 5, 2026 | Barclays | maintain | Overweight → Overweight | $22 | 53% |
| Nov 13, 2025 | BMO Capital | initiate | — → Outperform | $27 | 53% |
| Nov 7, 2025 | Barclays | maintain | Overweight → Overweight | $29 | 53% |
| Nov 7, 2025 | Evercore ISI Group | maintain | Outperform → Outperform | $28 | 58% |
| Nov 7, 2025 | Needham | maintain | Buy → Buy | $28 | 50% |
| Oct 22, 2025 | Barclays | maintain | Overweight → Overweight | $28 | 53% |
| Sep 5, 2025 | Baird | initiate | — → Neutral | $24 | 55% |
| Aug 8, 2025 | Canaccord Genuity | maintain | Buy → Buy | $28 | 48% |
| Aug 8, 2025 | Barclays | maintain | Overweight → Overweight | $24 | 53% |
| Aug 8, 2025 | Needham | maintain | Buy → Buy | $24 | 50% |
| Jul 9, 2025 | Evercore ISI Group | maintain | Outperform → Outperform | $23 | 58% |
| Jul 1, 2025 | JP Morgan | initiate | — → Overweight | $20 | 54% |
| Jul 1, 2025 | Morgan Stanley | initiate | — → Overweight | $25 | 54% |
| Jul 1, 2025 | Goldman Sachs | initiate | — → Buy | $29 | 54% |
| Jul 1, 2025 | Barclays | initiate | — → Overweight | $21 | 53% |
| Jul 1, 2025 | Needham | initiate | — → Buy | $23 | 50% |
| Jul 1, 2025 | Canaccord Genuity | initiate | — → Buy | $27 | 48% |
Price Target Trend
Jun 16, 2026 Latest: $28.42 Oct 25, 2026
EPS Estimates
+1y $0.56
Lo: $0.39 Hi: $0.66
5 analysts 0y $0.44
Lo: $0.38 Hi: $0.48
5 analysts 0q $0.10
Lo: $0.08 Hi: $0.12
5 analysts +1q $0.11
Lo: $0.09 Hi: $0.13
5 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days